With the administration of 72,20,642 vaccine doses in the last 24 hours, India’s COVID-19 According to the provisional reports of the Ministry of Health and Family Welfare, the vaccination coverage has crossed the milestone of 84 crores (84,15,18,026).
Here are the latest updates on India’s COVID-19 vaccination campaign:
Zydus Cadila’s indigenously developed needle-free COVID-19 vaccine ZyCoV-D received emergency use authorization from the Drugs Controller General of India last month and will be administered to people aged 12 years and above.
With the Emergency Use Authorization (EUA), ZyCoV-D became the first vaccine to be administered to people in the age group of 12-18 years in India.
The vaccine, ZyCoV-D, uses a portion of the genetic material from the virus that carries instructions in the form of DNA or RNA to make specific proteins that the immune system recognizes and responds to.
-Unlike most COVID-19 vaccines, which require two doses or even a single dose, ZyCoV-D is administered in three doses.
The listed generic drug maker as Cadila Healthcare Ltd aims to make 100 million to 120 million doses of ZyCoV-D annually and has already started stocking the vaccine.
NITI Aayog Member (Health) Dr VK Paul said that preparations are on to bring Zydus Cadila’s DNA vaccine into practical shape and implementation and there have been repeated discussions.
-Paul also said that the results of Covaxin for children’s vaccines are in the final stages and are expected soon. The results will be submitted to the drug regulator. Then the subject expert committee will look into it and once the regulator gives its approval, it can be used, he said.
Don’t miss a story! Stay connected and informed with Mint.
download
Our App Now!!
.